Exagen Inc. (XGN)

USD 6.02

(-1.95%)

Total Liabilities Summary of Exagen Inc.

  • Exagen Inc.'s latest annual total liabilities in 2023 was 34.25 Million USD , down -21.73% from previous year.
  • Exagen Inc.'s latest quarterly total liabilities in 2024 Q2 was 31.72 Million USD , up 2.94% from previous quarter.
  • Exagen Inc. reported annual total liabilities of 43.76 Million USD in 2022, up 13.64% from previous year.
  • Exagen Inc. reported annual total liabilities of 38.5 Million USD in 2021, up 5.4% from previous year.
  • Exagen Inc. reported quarterly total liabilities of 31.72 Million USD for 2024 Q2, up 2.94% from previous quarter.
  • Exagen Inc. reported quarterly total liabilities of 34.25 Million USD for 2023 Q4, up 2.47% from previous quarter.

Annual Total Liabilities Chart of Exagen Inc. (2023 - 2012)

Historical Annual Total Liabilities of Exagen Inc. (2023 - 2012)

Year Total Liabilities Total Liabilities Growth
2023 34.25 Million USD -21.73%
2022 43.76 Million USD 13.64%
2021 38.5 Million USD 5.4%
2020 36.53 Million USD 11.9%
2019 32.65 Million USD -8.34%
2018 35.62 Million USD 42.32%
2017 25.02 Million USD 0.0%
2015 36.81 Million USD 17.97%
2014 31.2 Million USD 95.03%
2013 16 Million USD 148.29%
2012 6.44 Million USD 0.0%

Peer Total Liabilities Comparison of Exagen Inc.

Name Total Liabilities Total Liabilities Difference
Aclaris Therapeutics, Inc. 40.22 Million USD 14.856%
Applied DNA Sciences, Inc. 8.77 Million USD -290.128%
Aspira Women's Health Inc. 8.62 Million USD -297.009%
Biodesix, Inc. 94.51 Million USD 63.763%
BioNexus Gene Lab Corp. 1.74 Million USD -1866.197%
bioAffinity Technologies, Inc. 3.36 Million USD -917.438%
bioAffinity Technologies, Inc. 3.36 Million USD -917.438%
Bionano Genomics, Inc. 118.24 Million USD 71.035%
CareDx, Inc 223.28 Million USD 84.661%
Check-Cap Ltd. 1.33 Million USD -2475.188%
Castle Biosciences, Inc. 86.54 Million USD 60.424%
DarioHealth Corp. 38.24 Million USD 10.446%
Exact Sciences Corporation 3.32 Billion USD 98.97%
Fulgent Genetics, Inc. 139.82 Million USD 75.505%
Guardant Health, Inc. 1.62 Billion USD 97.896%
ICON Public Limited Company 7.74 Billion USD 99.558%
IDEXX Laboratories, Inc. 1.77 Billion USD 98.071%
Illumina, Inc. 4.36 Billion USD 99.216%
Intelligent Bio Solutions Inc. 5.59 Million USD -512.08%
iSpecimen Inc. 6.07 Million USD -463.502%
Standard BioTools Inc. 159.86 Million USD 78.576%
MDxHealth SA 121.92 Million USD 71.909%
23andMe Holding Co. 206.64 Million USD 83.426%
Medpace Holdings, Inc. 1.09 Billion USD 96.88%
Myriad Genetics, Inc. 312.9 Million USD 89.054%
Mainz Biomed B.V. 12.15 Million USD -181.666%
ENDRA Life Sciences Inc. 1.09 Million USD -3027.405%
NeoGenomics, Inc. 739.69 Million USD 95.37%
Neogen Corporation 1.44 Billion USD 97.622%
Inotiv, Inc. 588.04 Million USD 94.176%
Natera, Inc. 691.79 Million USD 95.049%
OPKO Health, Inc. 622.47 Million USD 94.498%
Psychemedics Corporation 6.59 Million USD -419.097%
Prenetics Global Limited 44.01 Million USD 22.183%
Prenetics Global Limited 44.01 Million USD 22.183%
Precipio, Inc. 3.67 Million USD -832.734%
Personalis, Inc. 95.65 Million USD 64.195%
RadNet, Inc. 2.07 Billion USD 98.348%
Sera Prognostics, Inc. 25.28 Million USD -35.467%
Sotera Health Company 2.68 Billion USD 98.725%
Neuronetics, Inc. 81.64 Million USD 58.048%
Star Equity Holdings, Inc. 21.67 Million USD -58.016%
Star Equity Holdings, Inc. 21.67 Million USD -58.016%
Trinity Biotech plc 83.38 Million USD 58.925%
Twist Bioscience Corporation 152.97 Million USD 77.61%